245 related articles for article (PubMed ID: 35290888)
21. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms.
Al-Enazi NM; Alsamhary K; Ameen F
Environ Res; 2023 May; 225():115599. PubMed ID: 36898420
[TBL] [Abstract][Full Text] [Related]
23. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
Peixoto LR; Rosalen PL; Ferreira GL; Freires IA; de Carvalho FG; Castellano LR; de Castro RD
Arch Oral Biol; 2017 Jan; 73():179-185. PubMed ID: 27771586
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
25. Butyl isothiocyanate exhibits antifungal and anti-biofilm activity against Candida albicans by targeting cell membrane integrity, cell cycle progression and oxidative stress.
Patil SB; Basrani ST; Chougule SA; Gavandi TC; Karuppayil SM; Jadhav AK
Arch Microbiol; 2024 May; 206(6):251. PubMed ID: 38727840
[TBL] [Abstract][Full Text] [Related]
26. Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Phytomedicine; 2015 Oct; 22(11):975-80. PubMed ID: 26407939
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm.
Casalinuovo IA; Sorge R; Bonelli G; Di Francesco P
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1413-1420. PubMed ID: 28387883
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
Lee JH; Kim YG; Lee J
Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
[TBL] [Abstract][Full Text] [Related]
29. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells.
Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M
Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454
[TBL] [Abstract][Full Text] [Related]
30. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
[TBL] [Abstract][Full Text] [Related]
31. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
32. The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.
Paulone S; Ardizzoni A; Tavanti A; Piccinelli S; Rizzato C; Lupetti A; Colombari B; Pericolini E; Polonelli L; Magliani W; Conti S; Posteraro B; Cermelli C; Blasi E; Peppoloni S
PLoS One; 2017; 12(7):e0181278. PubMed ID: 28704490
[TBL] [Abstract][Full Text] [Related]
33. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
[TBL] [Abstract][Full Text] [Related]
34. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
35. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
36. β-citronellol alters cell surface properties of Candida albicans to influence pathogenicity related traits.
Sharma Y; Rastogi SK; Perwez A; Rizvi MA; Manzoor N
Med Mycol; 2020 Jan; 58(1):93-106. PubMed ID: 30843057
[TBL] [Abstract][Full Text] [Related]
37. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.
Nieminen MT; Novak-Frazer L; Rautemaa V; Rajendran R; Sorsa T; Ramage G; Bowyer P; Rautemaa R
PLoS One; 2014; 9(5):e97864. PubMed ID: 24867320
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Mohammadi F; Hemmat N; Bajalan Z; Javadi A
Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
40. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (
Radhakrishnan VS; Reddy Mudiam MK; Kumar M; Dwivedi SP; Singh SP; Prasad T
Int J Nanomedicine; 2018; 13():2647-2663. PubMed ID: 29760548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
